Company no longer exists

Phylogica Ltd ✟

Suite 3, 257 York St
6008 Subiaco
Australia
Profile News

About Phylogica

Phylogica Limited is a biotechnology company based in Perth, Australia and Oxford UK, with a world-class drug discovery platform harnessing the rich biodiversity of nature to discover novel peptide therapeutics. The Company was incorporated in 2001 as a spin out from the Telethon Institute for Child Health Research (Perth, Australia) and the Fox Chase Cancer Center (Philadelphia, USA).

Read more about Phylogica

Phylogica no longer exists.

News about Phylogica

Phylogica

31-Mar-2015 | research and development

Phylogica Peptide Fusion Kills Aggressive Breast Cancer Cells

A pilot study by Associate Professor Pilar Blancafort, a member of the Harry Perkins Institute of Medical Research, shows that Phylogica’s cell penetrating ...

Read news
Phylogica

23-Dec-2014 | business & finance

Phylogica enters into Research and Licensing Agreement with Genentech

Phylogica Ltd  announced that it has extended its collaboration with Genentech by entering into a Research and Licensing agreement to discover novel ...

Read news
Phylogica

04-Jan-2012 | business & finance

Phylogica licenses technology to Janssen Biotech, Inc.

Phylogica Ltd  announced a Collaboration and Option agreement with Janssen Biotech, Inc., to discover new classes of drugs derived from Phylogica’s ...

Read news
Phylogica

11-May-2011 | research and development

Phylogica and Pepscan enter collaboration to optimise therapeutic phylomer drug candidates

Phylogica Ltd and Pepscan Therapeutics announced that they have entered a Research Collaboration and Option Agreement to evaluate the combination of their ...

Read news
Phylogica

11-Mar-2011 | science

Phylogica forms target discovery spin-off with University of Cambridge

Phylogica Ltd  will partner with researchers from the University of Cambridge in a spin-off company to pursue a novel application of its Phylomer® peptides ...

Read news
Phylogica

24-Feb-2011 | business & finance

Phylogica and Isogenica: Strategic alliance fast tracking screening of drug discovery targets

Phylogica Ltd  and Isogenica Ltd have succeeded in a proof of concept project demonstrating compatibility of Isogenica’s proprietary CIS in-vitro display ...

Read news
Phylogica

22-Feb-2011 | research and development

Phylogica: New potential for treating brain injury

Novel compound protects neural tissue, reduces inflammation

Read news
Phylogica

18-Feb-2011 | business & finance

Phylogica Announces Successful Collaboration with Roche

Phylogica Ltd announced successful completion of the initial research objectives of its collaboration with Roche. The objective of the first stage of the ...

Read news
Show more news about Phylogica